FGL2 and atherosclerosis: However, emerging evidence linking angiopoietin-like protein 2 with chronic inflammation in RA, atherosclerosis, diabetes, and cancer47, and reports of fibroleukin regulating DC maturation51 and macrophage activation52, support the idea of immunomodulatory roles for FRePs.